News
TXG
57.69
-2.39%
-1.41
Hertz, 10x Genomics, Bloom Energy, FuelCell Energy, and Plug Power stocks trade down, what you need to know
Barchart · 1d ago
Stephens Remains a Hold on 10x Genomics (TXG)
TipRanks · 2d ago
Learn Why The Bull Case For 10x Genomics Stock Could Change Following Raised Revenue Outlook
Simply Wall St · 2d ago
10x Genomics Earnings Call Highlights Atera Momentum
TipRanks · 2d ago
10x Genomics' Xenium Platform To Be Deployed By Fudan University Shanghai Cancer Center, Shanghai Precision Diagnostics In 24-Month Trial
Benzinga · 3d ago
Shanghai Precision Diagnostics and Fudan University Shanghai Cancer Center Launch Breast Cancer Biomarker Study Using 10x Genomics' Xenium Platform
PR Newswire · 3d ago
10x Genomics Price Target Cut to $65.00/Share From $70.00 by JP Morgan
Dow Jones · 3d ago
10x Genomics Is Maintained at Neutral by JP Morgan
Dow Jones · 3d ago
JP Morgan Maintains Neutral on 10x Genomics, Lowers Price Target to $65
Benzinga · 3d ago
10x Genomics Price Target Cut to $70.00/Share From $110.00 by Barclays
Dow Jones · 4d ago
10x Genomics Is Maintained at Overweight by Barclays
Dow Jones · 4d ago
Barclays Maintains Overweight on 10x Genomics, Lowers Price Target to $70
Benzinga · 4d ago
10x Genomics price target lowered to $65 from $70 at JPMorgan
TipRanks · 4d ago
Cathie Wood's Ark Invest buys $96M of SpaceX, adds to Nvidia and AMD; trims Broadcom
Seeking Alpha · 4d ago
Weekly Report: what happened at TXG last week (1102-1106)?
Weekly Report · 4d ago
Is 10x Genomics (TXG) Cheap As It Lifts Full Year Guidance?
Simply Wall St · 5d ago
10x Genomics price target lowered to $65 from $80 at BofA
TipRanks · 6d ago
10x Genomics (TXG) Stock Looks Overvalued After Its 289% Run
Simply Wall St · 6d ago
Escalating Governance Burdens and Limited D&O Coverage Put 10x Genomics’ Financials at Risk
TipRanks · 6d ago
10x Genomics (TXG) Receives a Hold from Bank of America Securities
TipRanks · 6d ago
More
Webull provides a variety of real-time TXG stock news. You can receive the latest news about 10X Genomics, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TXG
10x Genomics, Inc. is a life science technology company. The Company's integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems. Its products are used across diverse fields, from cancer research and immunology to neuroscience and developmental biology. Its commercial product portfolio is made up of its Single Cell and Spatial solutions. Its products include its instruments, which include its Chromium instruments, its Visium CytAssist and its Xenium Analyzer, and its consumables, which include proprietary microfluidic chips, slides, reagents and other consumables for its Single Cell and Spatial solutions. It bundles its software with these products to guide customers through the workflow, from sample preparation through analysis and visualization. It also provides post-warranty service contracts for its instruments.